Specifications TableSubject area*Biology*More specific subject area*Genetics*Type of data*Table*How data was acquired*MALDI/TOF mass spectrometry using Sequenom MassARRAY 4.0 platform (Agena Bioscience™)*Data format*Raw and analyzed data*Experimental factors*Total genomic DNA was isolated from buffy coat using the standard phenol-chloroform method.*Experimental features*DNA samples were genotyped using the Sequenom MassARRAY® iPLEX platform, which is based on MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight) mass spectrometry*Data source location*Belgorod, Russia*Data accessibility*The data is available with this article***Value of the Data**•The frequencies of alleles and genotypes of rs1514175 *TNNI3K*, rs713586 RBJ, rs887912 *FANCL*, rs2241423 *MAP2K5*, and rs12444979 *GPRC5B* among Russian women with different body mass index (underweight, normal weight, overweight, obesity) vary, but do not differ significantly.•The genetic polymorphisms in *TNNI3K, RBJ, FANCL, MAP2K5, GPRC5B* genes may play a role in body mass index.•The data on the allele and genotype frequencies are an important resource for understanding genetic structure of different populations.•The data can be used to study a genetic basis of body mass index and BMI-associated multifactorial diseases (obesity, arterial hypertension, metabolic syndrome, stroke, coronary artery disease, uterine leiomyoma, and the others) in various populations.

1. Data {#sec1}
=======

The dataset represents the raw data (supplementary Table), frequencies of alleles and genotypes for five single nucleotide polymorphisms (SNPs) of 5 genes, rs1514175 *TNNI3K*, rs713586 RBJ, rs887912 *FANCL*, rs2241423 *MAP2K5*, and rs12444979 *GPRC5B* in Russian women ([Table 1](#tbl1){ref-type="table"}). These SNPs were associated with body mass index (BMI) in previously published genome-wide and candidate gene association studies \[[@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10]\]. The dataset frequencies of the SNP alleles and genotypes were divided into five groups according to the BMI of the participants: all samples, underweight (BMI\<18.50), normal weight (18.50--24.99), overweight (25.00--29.99), and obese (\>30.00). No significant differences in the allele and genotype frequencies between the groups with underweight (BMI\<18.50), normal weight (18.50--24.99), overweight (25.00--29.99) and obese (\>30.00) (p \> 0.05) were determined.Table 1The frequencies of alleles and genotypes for single nucleotide polymorphisms (SNPs) rs1514175 *TNNI3K*, rs713586 RBJ, rs887912 *FANCL*, rs2241423 *MAP2K5*, rs12444979 *GPRC5B* in the sample of Russian women.Table 1SNP genotype or alleleAll (n = 716)Body mass indexnfrequencyMean, kg/m^2^underweight (BMI\<18.50) (n = 40)normal weight (18.50--24.99) (n = 445)overweight (25.00--29.99) (n = 159)obese (\>30.00) (n = 72)nfrequencynfrequencynfrequencynfrequencyrs1514175 *TNNI3K*CC2750.384123.84 ± 4.46210.52501730.3888590.3710220.3056CT3310.462324.16 ± 4.37110.27502060.4629700.4403440.6111TT1100.153623.13 ± 3.7080.2000660.1483300.188760.0833C8810.6152--530.66255520.62021880.5912880.6111T5510.3848--270.33753380.37981300.4088560.3889rs713586 RBJTT2380.332423.61 ± 4.13180.45001460.3281490.3082250.3472TC3400.474924.08 ± 4.65180.45002120.4764730.4591370.5139CC1380.192723.92 ± 3.7440.1000870.1955370.2327100.1389T8160.5698--540.67505040.56631710.5377870.6042C6160.4302--260.32503860.43371470.4623570.3958rs887912 *FANCL*GG4370.610323.96 ± 4.47270.67502700.6067950.5975450.6250GA2380.332423.68 ± 4.19120.30001520.3416500.3145240.3333AA410.057324.11 ± 3.3010.0250230.0517140.088030.0417G11120.7765--660.82506920.77752400.75471140.7917A3200.2235--140.17501980.2225780.2453300.2083rs2241423 *MAP2K5*GG4740.662023.81 ± 4.11270.67502880.64711150.7233440.6111GA2130.297523.93 ± 4.65110.27501410.3169370.2327240.3333AA290.040524.72 ± 5.1720.0500160.036070.044040.0556G11610.8108--650.81257170.80562670.83961120.7778A2710.1892--150.18751730.1944510.1604320.2222rs12444979 *GPRC5B*CC5240.731823.99 ± 4.36290.72503200.71911180.7421570.7917CT1750.244423.56 ± 4.25110.27501140.2562370.2327130.1805TT170.023823.96 ± 3.79----110.024740.025220.0278C12230.8541--690.86257540.84722730.85851270.8819T2090.1459--110.13751360.1528450.1415170.1181

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Study subjects {#sec2.1}
-------------------

From 2009 to 2013, women referred to the Perinatal Centre of the Belgorod Regional Clinical Hospital of St. Joasaph were enrolled. The participants were unrelated Russian women born in Central Russia \[[@bib11]\]. Some exclusion criteria were adopted: benign tumors and hyperplastic disorders of the reproductive organs (endometriosis, leiomyoma, and endometrial hyperplasia), malignant tumors of a small pelvis and breast, severe autoimmune diseases, chronic severe diseases of the vital organs (heart, respiratory or renal failure). A total of 716 women met the criteria. This study was approved by the Regional Ethics Committee of Belgorod State University and informed consents were obtained from all participants.

The anthropometric characteristics were obtained by standard methods \[[@bib12]\]: a portable stadiometer was used for measurement of height; weight was measured in an upright position, using a calibrated balance beam scale. 5 groups were formed according to BMI: total sample set, sample set with the underweight (BMI\<18.50), normal weight (18.50--24.99), overweight (25.00--29.99) and obese (\>30.00).

2.2. Blood sample collection and DNA handling {#sec2.2}
---------------------------------------------

Whole blood specimens were collected from each participant using a plastic tubes (Vacutainer®) containing 0.5 M EDTA solution (рН = 8.0) and genomic DNA was isolated from peripheral blood leukocytes using the standard phenol-chloroform method. The isolated DNA was stored at −80°С.

2.3. SNP selection {#sec2.3}
------------------

Five SNPs in five genes, rs1514175 *TNNI3K*, rs713586 RBJ, rs887912 *FANCL*, rs2241423 *MAP2K5*, and rs12444979 *GPRC5B* were selected for the analysis according to the following criteria \[[@bib13]\]: 1) Previously reported genome-wide and candidate genes associations with body mass index (BMI) and obesity, 2) Regulatory potential (regSNP), 3) Effect on gene expression (eSNP), and 4) Tag value (tagSNP) and 5) MAF \> 5%.

The selected loci were associated with BMI in previously published genome-wide and candidate gene association studies ([Table 2](#tbl2){ref-type="table"}) and have functional significance: all SNPs appear to have a significant regulatory potential ([Table 3](#tbl3){ref-type="table"}) (determined using the online tools HaploReg, v4.1 update November 05, 2015, <https://pubs.broadinstitute.org/mammals/haploreg/haploreg.php>) and 4 SNPs to influence gene expression level ([Table 4](#tbl4){ref-type="table"}) (determined using the GTExportal data, <http://www.gtexportal.org/>).Table 2The literature data about associations of the studied polymorphisms with body mass index and obesity.Table 2Chr (1)SNP (2Gene/RegionPhenotypeAssociation (significance) (associated allele/genotype)Reference1rs1514175*TNNI3K***Body mass index0.07 kg/m**^**2**^**(p** = **8 x10**^**−14**^**) (А)**\[[@bib1]\]**Body mass index0.06 unit (p** = **3 x10**^**−11**^**) (А)**\[[@bib3]\]Body mass index0.20 kg/m^2^ (p = 7.7 × 10^−4^) (A)\[[@bib4]\]2rs713586*RBJ***Body mass index0.14 kg/m**^**2**^**(p** = **6 x10**^**−22**^**) (С)**\[[@bib1]\]2rs887912*FANCL***Body mass index0.1 kg/m**^**2**^**(p** = **2 x10**^**−12**^**) (T)**\[[@bib1]\]**Obesity (class I)OR** = **1.07 (p** = **1 x10**^**−10**^**) (T)**\[[@bib2]\]**Obesity (class II)OR** = **1.1 (p** = **6 x10**^**−9**^**) (T)**\[[@bib2]\]15rs2241423*MAP2K5***Body mass index0.13 kg/m**^**2**^**(p** = **1 x10**^**−18**^**) (G)**ObesityOR = 0.79 (p = 0.029) (A)\[[@bib1]\]Body mass index−0.092 unit (p = 0.028) (A)\[[@bib5]\]Children obesity(p \< 0.005)\[[@bib5]\]ObesityOR = 1.34 (0.001) (G)\[[@bib6]\]Adulthood body mass index(p \< 0.05)\[[@bib7]\]Body mass index0.11 kg/m^2^ (p = 0.028) (G)\[[@bib8]\]16rs12444979*GPRC5B***Body mass index0.17 kg/m**^**2**^**(p** = **3 x10**^**−21**^**) (C)**\[[@bib1]\]Body mass index(p \< 0.05)\[[@bib9]\]Body mass index (EA)(p = 0.014)\[[@bib10]\]Body fat mass (EA)(p = 0.002)\[[@bib10]\][^1]Table 3Regulatory effects of the 5 SNPs of the TNNI3K, RBJ, FANCL, MAP2K5, and GPRC5B genes (HaploReg, v4.1, update November 05, 2015) (<https://pubs.broadinstitute.org/mammals/haploreg/haploreg.php>).Table 3chrpos (hg38)variantReference alleleAlternative alleleAFRAMRASNEURSiPhyPromoterEnhancerDNAseProteinsMotifsNHGRI/EBIGRASP QTLSelected eQTLGENCODEdbSNP**freqfreqfreqfreqconshistone markshistone marksboundchangedGWAS hitshitshitsgenesfunc annot**174525960rs1514175AG0.310.420.20.56ESC, ESDR, IPSCCOMP1,ERalpha-a2 hits2 hitsFPGT-TNNI3Kintronic224935139rs713586TC0.90.430.460.46Pbx3,SP2,TATA1 hit3 hits34 hits8.5kb 3′ of DNAJC27259075742rs887912TC0.940.8310.73Hoxa5,Znf1433 hits12kb 3′ of AC007092.11567794500rs2241423GA0.40.430.60.23IPSC1 hit1 hit16 hitsMAP2K5intronic1619922278rs12444979CT0.090.0600.12LBP-11 hit70 hits32kb 3′ of AC134300.1Table 4The *cis*-eQTL values of the 5 SNPs of the TNNI3K, RBJ, FANCL, MAP2K5, and GPRC5B genes (according to Genotype-Tissue Expression (GTEx) (<http://www.gtexportal.org/>)).Table 4chrSNPGeneGene expressionReference alleleAlternative alleleEffect Size (β)*P*-ValueTissue1rs1514175*TNNI3KLRRIQ3*AG0.250.0000045Thyroid2rs713586*RBJADCY3*TC0.310.00000018Skin - Sun Exposed (Lower leg)rs713586*RBJCENPO*TC0.712.9E-38Whole Bloodrs713586*RBJADCY3*TC0.515.3E-22Whole Bloodrs713586*RBJADCY3*TC−0.230.0000000000000063Nerve - Tibialrs713586*RBJCENPO*TC0.280.00000000000031Artery - Tibialrs713586*RBJDNAJC27*TC−0.20.00000000012Nerve - Tibialrs713586*RBJDNAJC27-AS1*TC0.290.0000000003Whole Bloodrs713586*RBJDNAJC27-AS1*TC−0.270.0000000014Esophagus - Muscularisrs713586*RBJCENPO*TC−0.390.0000000042Brain - Cerebellumrs713586*RBJADCY3*TC0.230.0000000091Artery - Tibialrs713586*RBJADCY3*TC0.180.000000014Adipose - Subcutaneousrs713586*RBJCENPO*TC−0.410.00000015Cells - EBV-transformed lymphocytesrs713586*RBJADCY3*TC0.230.00000024Lungrs713586*RBJADCY3*TC0.180.0000006Adipose - Visceral (Omentum)rs713586*RBJCENPO*TC−0.150.00000079Skin - Sun Exposed (Lower leg)rs713586*RBJCENPO*TC0.180.0000011Adipose - Subcutaneousrs713586*RBJDNAJC27-AS1*TC0.230.0000015Adipose - Visceral (Omentum)rs713586*RBJADCY3*TC−0.330.0000026Pituitaryrs713586*RBJDNAJC27-AS1*TC−0.140.000004Skin - Not Sun Exposed (Suprapubic)rs713586*RBJADCY3*TC−0.150.000016Nerve - Tibialrs713586*RBJEFR3B*TC0.190.000031Lungrs713586*RBJPOMC*TC−0.210.000031Heart - Atrial Appendage15rs2241423*MAP2K5MAP2K5*GA−0.324.1E-19Artery - Tibialrs2241423*MAP2K5MAP2K5*GA−0.40.0000000000000029Heart - Atrial Appendagers2241423*MAP2K5MAP2K5*GA−0.320.000000000000012Adipose - Subcutaneousrs2241423*MAP2K5MAP2K5*GA−0.270.0000000000001Thyroidrs2241423*MAP2K5SKOR1*GA−0.30.0000000000019Lungrs2241423*MAP2K5SKOR1*GA−0.320.0000000000035Thyroidrs2241423*MAP2K5SKOR1*GA−0.30.000000000014Muscle - Skeletalrs2241423*MAP2K5MAP2K5*GA−0.260.000000000015Whole Bloodrs2241423*MAP2K5SKOR1*GA−0.40.000000000073Heart - Left Ventriclers2241423*MAP2K5SKOR1*GA−0.290.00000000021Adipose - Subcutaneousrs2241423*MAP2K5SKOR1*GA−0.350.00000000037Adipose - Visceral (Omentum)rs2241423*MAP2K5MAP2K5*GA−0.280.00000000092Esophagus - Muscularisrs2241423*MAP2K5SKOR1*GA−0.260.0000000014Artery - Tibialrs2241423*MAP2K5SKOR1*GA−0.230.0000000062Skin - Sun Exposed (Lower leg)rs2241423*MAP2K5MAP2K5*GA−0.220.0000000094Lungrs2241423*MAP2K5MAP2K5*GA−0.290.000000011Artery - Aortars2241423*MAP2K5SKOR1*GA−0.250.000000019Skin - Not Sun Exposed (Suprapubic)rs2241423*MAP2K5MAP2K5*GA−0.270.000000054Nerve - Tibialrs2241423*MAP2K5SKOR1*GA−0.20.000000095Nerve - Tibialrs2241423*MAP2K5SKOR1*GA−0.320.00000011Artery - Aortars2241423*MAP2K5MAP2K5*GA−0.270.00000012Adipose - Visceral (Omentum)rs2241423*MAP2K5SKOR1*GA−0.480.00000013Pituitaryrs2241423*MAP2K5SKOR1*GA−0.30.00000013Breast - Mammary Tissuers2241423*MAP2K5SKOR1*GA−0.240.00000018Esophagus - Muscularisrs2241423*MAP2K5MAP2K5*GA−0.250.00000019Breast - Mammary Tissuers2241423*MAP2K5MAP2K5*GA−0.230.0000009Heart - Left Ventriclers2241423*MAP2K5SKOR1*GA−0.290.0000063Esophagus - Gastroesophageal Junctionrs2241423*MAP2K5SKOR1*GA−0.510.000011Ovaryrs2241423*MAP2K5SKOR1*GA−0.250.000012Colon - Sigmoidrs2241423*MAP2K5MAP2K5*GA−0.270.000013Esophagus - Gastroesophageal Junctionrs2241423*MAP2K5SKOR1*GA−0.20.000016Colon - Transversers2241423*MAP2K5MAP2K5*GA−0.380.000017Pituitaryrs2241423*MAP2K5RP11-34F13.2*GA−0.290.00004Thyroid16rs12444979*GPRC5BKNOP1*CT0.640.00000000000037Adipose - Subcutaneousrs12444979*GPRC5BKNOP1*CT0.810.00000000000000049Adipose - Visceral (Omentum)rs12444979*GPRC5BKNOP1*CT0.660.00000000012Adrenal Glandrs12444979*GPRC5BKNOP1*CT0.780.000000000000000043Artery - Aortars12444979*GPRC5BKNOP1*CT0.670.0000000033Artery - Coronaryrs12444979*GPRC5BKNOP1*CT0.430.0000026Artery - Tibialrs12444979*GPRC5BKNOP1*CT0.770.0000067Brain - Cerebellumrs12444979*GPRC5BKNOP1*CT0.890.0000000056Brain - Hypothalamusrs12444979*GPRC5BKNOP1*CT0.820.0000009Brain - Nucleus accumbens (basal ganglia)rs12444979*GPRC5BKNOP1*CT0.810.00000000000071Breast - Mammary Tissuers12444979*GPRC5BKNOP1*CT0.730.0000015Cells - EBV-transformed lymphocytesrs12444979*GPRC5BKNOP1*CT0.690.000000062Colon - Sigmoidrs12444979*GPRC5BKNOP1*CT0.510.0000000005Colon - Transversers12444979*GPRC5BKNOP1*CT0.890.00000000000000071Esophagus - Gastroesophageal Junctionrs12444979*GPRC5BKNOP1*CT0.580.00000000000000021Esophagus - Mucosars12444979*GPRC5BKNOP1*CT0.751.6E-19Esophagus - Muscularisrs12444979*GPRC5BKNOP1*CT0.730.000000005Heart - Atrial Appendagers12444979*GPRC5BKNOP1*CT0.560.00000035Heart - Left Ventriclers12444979*GPRC5BKNOP1*CT0.650.00000000000000011Lungrs12444979*GPRC5BKNOP1*CT0.732.00E-20Muscle - Skeletalrs12444979*GPRC5BKNOP1*CT0.910.00000000000000013Nerve - Tibialrs12444979*GPRC5BKNOP1*CT10.000000042Ovaryrs12444979*GPRC5BKNOP1*CT10.000000000000029Pancreasrs12444979*GPRC5BKNOP1*CT0.920.000000000000016Skin - Not Sun Exposed (Suprapubic)rs12444979*GPRC5BKNOP1*CT0.794.1E-21Skin - Sun Exposed (Lower leg)rs12444979*GPRC5BKNOP1*CT0.950.000000059Spleenrs12444979*GPRC5BKNOP1*CT0.670.000000000000019Stomachrs12444979*GPRC5BKNOP1*CT0.550.000000000058Testisrs12444979*GPRC5BKNOP1*CT0.580.000000000006Thyroidrs12444979*GPRC5BKNOP1*CT0.770.0000015Vaginars12444979*GPRC5BKNOP1*CT0.350.000011Whole Bloodrs12444979*GPRC5BGPRC5B*CT−0.250.000046Adipose - Subcutaneous

2.4. SNP genotyping {#sec2.4}
-------------------

DNA samples were genotyped using the Sequenom MassARRAY® iPLEX platform. The procedure for DNA sample preparation and data quality control are described elsewhere \[[@bib12]\].

2.5. Statistical analysis {#sec2.5}
-------------------------

All polymorphisms were checked for their correspondence to the Hardy-Weinberg equilibrium (HWE) using the chi-square test. Differences in allele and genotype frequencies between the groups of underweight (BMI\<18.50), normal weight (18.50--24.99), overweight (25.00--29.99), and obese (\>30.00) women were determined using the Kruskall-Wallis test.
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[^1]: *Note:* The data from the GWAS are shown in bold.
